Dr. Christina Henson is an Assistant Professor of Radiation Oncology at the Stephenson Cancer Center (SCC) at the University of Oklahoma, where she serves as the residency program director and chairs the head and neck clinical research disease site group. She is the overall site PI for RTOG Foundation Trials, and SCC has been one of the highest accruing site to NRG/NCTN clinical trials for years running.

​

Dr. Henson's main research interests include clinical outcomes, mental health and coping, and disparities in head and neck cancer. She currently serves as NRG champion for EA3161, a phase II/III randomized study of maintenance nivolumab versus observation in patients with locally advanced, intermediate risk HPV positive oropharyngeal cancer. She has an actively enrolling investigator-initiated trial evaluating the combination of "QUAD SHOT" radiotherapy and pembrolizumab in patients with recurrent head and neck cancer. She is co-PI or co-investigator on several other trials spanning tissue analysis, gynecologic cancer, mHealth, supportive care, and medical applications of virtual reality platforms.